Skip to Main Content

Paper Details

Preseasonal treatment with either omalizumab or an inhaled corticosteroid boost to prevent fall asthma exacerbations.
J Allergy Clin Immunol
362
2015
IFN, Omalizumab, PBMCs, asthma, asthmatic, children, fall, omalizumab, participants
Author NameAffiliation
Stephen J Teach
Michelle A GillUniversity of Texas Southwestern Medical Center
Alkis TogiasNational Institute of Allergy and Infectious Diseases
Agustin Calatroni
Peter J GergenNational Institute of Allergy and Infectious Diseases
Jacqueline A PongracicAnn and Robert H. Lurie Children's Hospital of Chicago
Carolyn M KercsmarCincinnati Children's Hospital
Gurjit K Khurana HersheyCincinnati Children's Hospital
Rebecca S GruchallaUniversity of Texas Southwestern Medical Center
Andrew H LiuNational Jewish Health, Colo Children's Hospital Colorado and University of Colorado School of Medicine
Edward M ZorattiHenry Ford Hospital
Meyer KattanCollege of Physicians and Surgeons, Columbia University
James E GernUniversity of Wisconsin School of Medicine and Public Health
James E GernUniversity of Wisconsin School of Medicine and Public Health
William W BusseUniversity of Wisconsin School of Medicine and Public Health
  • 1 - 15

Datasets